Upadacitinib in the United States
16 medicine records from 7 holders carry this name in the official sources. Collected on November 11, 2026.
Medicines
| Name | Holder | Code |
|---|---|---|
| Rinvoq TABLET, EXTENDED RELEASE | AbbVie Inc. |
Product NDC
0074-1043Package NDC
0074-1043-14
|
| Rinvoq TABLET, EXTENDED RELEASE | AbbVie Inc. |
Product NDC
0074-2306Package NDC
0074-2306-30
|
| Rinvoq TABLET, EXTENDED RELEASE | AbbVie Inc. |
Product NDC
0074-2310Package NDC
0074-2310-20
|
| Rinvoq SOLUTION | AbbVie Inc. |
Product NDC
0074-2320Package NDC
0074-2320-01
|
| Upadacitinib TABLET | AbbVie Inc. |
Product NDC
0074-2241Package NDC
0074-2241-99
|
| Upadacitinib TABLET, EXTENDED RELEASE | AbbVie Inc. |
Product NDC
0074-2250Package NDC
0074-2250-99
|
| upadacitinib TABLET | AbbVie Inc. |
Product NDC
0074-2309Package NDC
0074-2309-99
|
| Upadacitinib POWDER | MSN Laboratories Private Limited |
Product NDC
14501-0111Package NDC
14501-0111-2
|
| Upadacitinib POWDER | Aurobindo Pharma Limited |
Product NDC
59651-788Package NDC
59651-788-37
|
| Upadacitinib POWDER | AbbVie SRL |
Product NDC
62526-2325Package NDC
62526-2325-9
|
| Upadacitinib POWDER | Curia Spain S.A.U. |
Product NDC
65089-0067Package NDC
65089-0067-1
|
| upadacitinib TABLET | AbbVie Ireland NL B.V. |
Product NDC
68513-1043Package NDC
68513-1043-9
|
| Upadacitinib TABLET | AbbVie Ireland NL B.V. |
Product NDC
68513-2306Package NDC
68513-2306-9
|
| Upadacitinib TABLET | AbbVie Ireland NL B.V. |
Product NDC
68513-2310Package NDC
68513-2310-9
|
| Upadacitinib POWDER | AbbVie Ireland NL B.V. |
Product NDC
68513-2320Package NDC
68513-2320-9
|
| upadacitinib POWDER | HONOUR LAB LIMITED |
Product NDC
82708-0001Package NDC
82708-0001-1
|
Need this list in your own system?
Every record on this page is available through the API, with its source, licence and retrieval date.